Sept. 11, 2025 — Newswise — A new Mayo Clinic study finds that many heart attacks in people under 65 — especially women ...
Cardiovascular Clinical Studies
This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.
September 15, 2025
Aug. 25, 2025 — Merck, known as MSD outside of the United States and Canada, has announced that new clinical trial and ...
August 25, 2025
Aug. 18, 2025 — (Newswise) It’s often mistaken for a heart attack, but Takotsubo cardiomyopathy — previously known as ...
August 21, 2025
Aug. 20, 2025 — A major international study published in Atherosclerosis* has found that routinely testing for ...
August 20, 2025
Aug. 14, 2025 — Analytics For Life, in collaboration with its U.S. commercial partner CorVista Health, announced they ...
August 15, 2025
Aug. 4, 2025 — Marea Therapeutics, Inc., a clinical-stage biotechnology company that develops next-generation medicines ...
August 04, 2025
July 16, 2025 — Medtronic has announced that the first patient has been enrolled in the PEripheral Onyx Liquid Embolic ...
July 22, 2025
July 7, 2025 — Medtronic announced that it has treated the first patient in its SPYRAL GEMINI Pilot program (including ...
July 07, 2025
June 11, 2025 — Bayer and the Broad Institute have have extended their research collaboration of 10 years by an ...
June 11, 2025
May 27, 2025 — Despite scientific advances in cardiovascular care, people in living in rural areas and other communities ...
May 27, 2025
May 20, 2025 — Shockwave Medical, Inc., part of Johnson & Johnson MedTechhas announced the 30-day primary endpoint ...
May 21, 2025
The American Heart Association recently announced that Dr. Christine E. Seidman, an internationally renowned physician ...
May 02, 2025
Jan. 13, — A new cohort study among 103,642 adults found that current use of cigars was associated with increased risk ...
January 14, 2025
Nov. 22, 2024 — BridgeBio Pharma, Inc. recently announced that the U.S. Food and Drug Administration (FDA) approved ...
November 25, 2024
Nov. 18, 2024 — Silence Therapeutics presented end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran, a ...
November 18, 2024